⌘K

Login Start Free

Home/Filings/4/0000864268-04-000017

4//SEC Filing

FEDIDA ANDRE DR 4

Accession 0000864268-04-000017

CIK 0000864268other

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 10:51 AM ET

Size

12.0 KB

Accession

0000864268-04-000017

Insider Transaction Report

Form 4

Period: 2003-11-11

BRADLEY PHARMACEUTICALS INCBDY

FEDIDA ANDRE DR

Director

Transactions

Discretionary Transaction
Stock Options (Right to buy)
2003-11-11$26.68/sh+1,667$44,476→ 3,333 total
Exercise: $26.68From: 2005-11-11Exp: 2013-11-10→ Common Stock (1,667 underlying)
Discretionary Transaction
Stock Options (Right to buy)
2003-11-11$26.68/sh+1,666$44,449→ 1,666 total
Exercise: $26.68From: 2004-11-11Exp: 2013-11-10→ Common Stock (1,666 underlying)

Holdings

Stock Options (Right to buy)
Exercise: $13.88From: 2002-03-11Exp: 2005-03-10→ Common Stock (1,250 underlying)
1,250
Stock Options (Right to buy)
Exercise: $12.40From: 2005-05-03Exp: 2012-05-02→ Common Stock (15,000 underlying)
15,000

Documents

1 file

4
c0001177964d20040210f4f.xmlPrimary
PRIMARY DOCUMENT

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

Entity typeother

Related Parties

1

filerCIK 0001177964

Filing Metadata

Form type: 4
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 10:51 AM ET
Size: 12.0 KB

View on SEC.gov